The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens
- 14 December 2003
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 5 (1) , 88-97
- https://doi.org/10.1038/ni1021
Abstract
Microbial pathogens use a variety of their surface molecules to bind to host extracellular matrix (ECM) components to establish an effective infection. However, ECM components can also serve as an integral part of the innate immunity. Mice lacking expression of mindin (spondin 2), a highly conserved ECM protein, have an impaired ability to clear bacterial infection, and mindin-deficient macrophages show defective responses to a broad spectrum of microbial stimuli. Moreover, mindin binds directly to bacteria and their components and functions as an opsonin for macrophage phagocytosis of bacteria. Thus, mindin is essential in the initiation of the innate immune response and represents a unique pattern-recognition molecule in the ECM for microbial pathogens.Keywords
This publication has 42 references indexed in Scilit:
- Toll-Like Receptor Signaling PathwaysScience, 2003
- Lipopolysaccharide EndotoxinsAnnual Review of Biochemistry, 2002
- Regulation of the TCRα repertoire by the survival window of CD4+CD8+ thymocytesNature Immunology, 2002
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- Toll-like receptors and innate immunityNature Reviews Immunology, 2001
- The Extra Domain A of Fibronectin Activates Toll-like Receptor 4Journal of Biological Chemistry, 2001
- The Lipopolysaccharide Structures ofSalmonella entericaSerovar Typhimurium andNeisseria gonorrhoeaeDetermine the Attachment of Human Mannose-Binding Lectin to Intact OrganismsInfection and Immunity, 2000
- Identification of Genes (SPON2 and C20orf2) Differentially Expressed between Cancerous and Noncancerous Lung Cells by mRNA Differential DisplayGenomics, 1999
- Phylogenetic Perspectives in Innate ImmunityScience, 1999
- Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)The Journal of Experimental Medicine, 1999